09.24.2025
Therapeutics
$2,452,718.00
24 months
The “NAGIC” Study: N-acetylglucosamine in ileal Crohn's disease
A clinical trial to test the effect of a dietary supplement, meant to aid glycosylation, in CD patients with and without a genetic variant which impedes proper glycosylation.